Depressed CD40 Ligand Expression Contributes to Reduced Gamma Interferon Production in Human Tuberculosis
Author:
Affiliation:
1. Center for Pulmonary and Infectious Disease Control1 and
2. Immunex Corporation, Seattle, Washington 981012
3. Departments of Cell Biology3 and
4. Medicine,4 University of Texas Health Center, Tyler, Texas 75710, and
Abstract
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Link
https://journals.asm.org/doi/pdf/10.1128/IAI.68.5.3002-3006.2000
Reference35 articles.
1. CD40 ligand is a T cell growth factor;Armitage R. J.;Eur. J. Immunol.,1993
2. CD40 ligand and its role in X-linked hyper-IgM syndrome;Callard R. E.;Immunol. Today,1993
3. CD40 ligand is required for protective cell-mediated immunity to Leishmania major;Campbell K. A.;Immunity,1996
4. Cutting edge: CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis;Campos-Neto A.;J. Immunol.,1998
5. Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40;DeKruyff R. H.;J. Immunol.,1997
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The molecular basis and downstream immune consequences of mycobacteria–host cell interactions;FEMS Microbiology Reviews;2023-03
2. A protein signature associated with active tuberculosis identified by plasma profiling and network-based analysis;iScience;2022-12
3. Strategies employed to evade the host immune response and the mechanism of drug resistance in Mycobacterium tuberculosis: In search of finding new targets;Current Pharmaceutical Biotechnology;2021-12-22
4. Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40/IL27 Regulation in Macrophages;Cancer Research;2021-10-12
5. Infectious Complications Predict Premature CD8+ T-cell Senescence in CD40 Ligand-Deficient Patients;Journal of Clinical Immunology;2021-01-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3